ALFA Finder| Revenue growth | -10% YoY consolidated; exports volume down 8%. |
|---|---|
| Margins | EBITDA margin at 22% vs 27% YoY; gross margins impacted. |
| Order book | Continues to support growth outlook for new products. |
| Demand visibility | Soft global agrochemical demand; domestic volume up 12%. |
| Management confidence | Long-term outlook remains intact despite current cyclical headwinds. |
Growth
Exports revenue declined 13.3% YoY on soft global demand; domestic revenue grew 2.8% with biologicals up 50%+
Outlook
Launching 5+ new products in FY27; ₹2,685 Mn capex in Q1; net cash balance increased to ₹37,939 Mn.
Risks
Pricing pressure from generics, delayed monsoon impacting Kharif sowing, and geopolitical tensions increasing input material costs.
Last quarter's promises, checked
Delivered
- Guided 25% EBITDA margin for FY26 → delivered 25% (= BEAT)
- Guided sequential revenue growth for Q4 FY26 → delivered Rs. 15,652 Mn (= BEAT)
- Guided Pharma growth → delivered 40% growth for full year (= BEAT)
Partly delivered
- Guided ETR for FY26 at 22% → delivered 22% (but warned of 24% future rise) (= PARTIAL)
Missed
- Guided positive growth for FY27 → delivered -10% revenue in Q1 FY27 (= MISS)
- Guided EBITDA margin profile → delivered 22% in Q1 FY27 vs 25% FY26 commitment (= MISS)
Investor Presentation filed with BSE, NSE: PIIND. Summary written with AI assistance from the document.
PI Industries Ltd: key numbers
- Share price
- ₹1,761.00
- Market cap
- ₹26,718 Cr
- Revenue (annual)
- ₹6,714 Cr
- Net profit (annual)
- ₹1,321 Cr
- P/E (TTM)
- 30.4×Sector 35.5×
- Promoter holding
- 46.09%+0.00% QoQ
- FII holding
- 14.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from PI Industries Ltd
All →PI Industries Earnings Call Transcript: Key Takeaways
PI Industries faces severe headwinds in its core AgChem export business, masking strong domestic and biological growth.
PI Industries Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue fell 9% to INR17,018Mn, EBITDA margin compressed to 14%, and PAT fell 70%. Domestic and Biologicals grew; agchem exports declined 18%.
PI Industries Q2 FY27 Results: Net Profit ₹122.2 Cr, Down 70.1% YoY
PI Industries Ltd reported revenue from operations of ₹1,702 Cr (-9.1% YoY) and net profit of ₹122.2 Cr (-70.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹122.2 Cr · -70.1% YoY
PI Industries Business Update
PI Industries unveiled Pioxaniliprole, India's first indigenously discovered insecticide molecule, which has received CIB&RC registration. The press release marks a milestone in the company's original crop-protection research.
PI Industries Board Meeting Date
PI Industries has intimated a board meeting on November 4, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The trading window is closed from October 1 to November 6, 2026.
PI Industries Other Announcement
PI Industries Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations. This is a routine regulatory compliance filing.